Biospace news

Syndicate content
RSS Feed for Biotech, Pharmaceutical and Clinical Research News | BioSpace (Generated by New Sloth)
URL: https://www.biospace.com/news/
Updated: 7 hours 48 min ago

Novartis Secures Phase III Fabhalta Win in IgAN as FDA Starts Priority Review

Tue, 04/16/2024 - 02:00
Novartis Secures Phase III Fabhalta Win in IgAN as FDA Starts Priority Review 4/16/2024

Intra-Cellular Touts Phase III Major Depressive Disorder Results for Antipsychotic Drug

Tue, 04/16/2024 - 02:00
Intra-Cellular Touts Phase III Major Depressive Disorder Results for Antipsychotic Drug 4/16/2024

Ultragenyx Eyes Pivotal Study After Mid-Stage Win in Angelman Syndrome

Tue, 04/16/2024 - 02:00
Ultragenyx Eyes Pivotal Study After Mid-Stage Win in Angelman Syndrome 4/16/2024

Pfizer, BioNTech Get Legal Pause in Moderna’s COVID-19 Vaccine Patent Lawsuit

Tue, 04/16/2024 - 02:00
Pfizer, BioNTech Get Legal Pause in Moderna’s COVID-19 Vaccine Patent Lawsuit 4/16/2024

FDA Puts Clinical Hold on Neumora’s Schizophrenia Drug Due to Preclinical Saf...

Mon, 04/15/2024 - 02:00
FDA Puts Clinical Hold on Neumora’s Schizophrenia Drug Due to Preclinical Saf... 4/15/2024

Roche Bispecific T Cell Engager Improves Survival in Lymphoma, Teeing up Label Expansion

Mon, 04/15/2024 - 02:00
Roche Bispecific T Cell Engager Improves Survival in Lymphoma, Teeing up Label Expansion 4/15/2024

FDA Adcomm Backs New Surrogate Endpoint for Accelerated Approvals in Blood Cancer

Mon, 04/15/2024 - 02:00
FDA Adcomm Backs New Surrogate Endpoint for Accelerated Approvals in Blood Cancer 4/15/2024

AbbVie Touts Long-Term Efficacy of Qulipta as Preventive Migraine Treatment

Mon, 04/15/2024 - 02:00
AbbVie Touts Long-Term Efficacy of Qulipta as Preventive Migraine Treatment 4/15/2024

Genentech Walks Away From $3B Allogeneic T-Cell Pact with Adaptimmune

Mon, 04/15/2024 - 02:00
Genentech Walks Away From $3B Allogeneic T-Cell Pact with Adaptimmune 4/15/2024

Regeneron Launches $500M Venture Capital Fund Skewed Toward Biotech

Mon, 04/15/2024 - 02:00
Regeneron Launches $500M Venture Capital Fund Skewed Toward Biotech 4/15/2024

Listen Up: Emerging Vocal Biomarker Could Aid ALS Drug Development

Mon, 04/15/2024 - 02:00
Listen Up: Emerging Vocal Biomarker Could Aid ALS Drug Development 4/15/2024

5 Promising MASH Therapies That Could Follow Madrigal’s Rezdiffra

Mon, 04/15/2024 - 02:00
5 Promising MASH Therapies That Could Follow Madrigal’s Rezdiffra 4/15/2024

4 Investigational Weight Loss Drugs That Could Change the Market

Mon, 04/15/2024 - 02:00
4 Investigational Weight Loss Drugs That Could Change the Market 4/15/2024

Moderna Moves Cambridge Employees Into New Headquarters

Thu, 04/04/2024 - 02:00
Moderna Moves Cambridge Employees Into New Headquarters 4/4/2024

How to Manage Your Manager: Tips for Managing Up

Thu, 04/04/2024 - 02:00
How to Manage Your Manager: Tips for Managing Up 4/4/2024

The Top 11 Companies Hiring in Biopharma Now

Thu, 04/04/2024 - 02:00
The Top 11 Companies Hiring in Biopharma Now 4/4/2024

WuXi AppTec Shared Client IP with Beijing, Say US Intelligence Officials: Reuters

Fri, 03/29/2024 - 02:00
WuXi AppTec Shared Client IP with Beijing, Say US Intelligence Officials: Reuters 3/29/2024

BMS’ Zeposia Fails to Meet Primary Endpoint in Phase III Crohn’s Trial

Fri, 03/29/2024 - 02:00
BMS’ Zeposia Fails to Meet Primary Endpoint in Phase III Crohn’s Trial 3/29/2024

Gilead Wins Label Expansion for Vemlidy to Treat Hepatitis B Virus in Kids

Fri, 03/29/2024 - 02:00
Gilead Wins Label Expansion for Vemlidy to Treat Hepatitis B Virus in Kids 3/29/2024

FDA Extends Review Period for Applied Therapeutics’ Govorestat by Three Months

Fri, 03/29/2024 - 02:00
FDA Extends Review Period for Applied Therapeutics’ Govorestat by Three Months 3/29/2024